BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2018
View Archived Issues
Microenvironment trouble underlies chemo brain
Read More
Antiviral response damages kidney in bacterial sepsis
Read More
New pyrrolidine sulfonamides as TRPV4 antagonists
Read More
DNA-encoded monoclonal antibody targeting PCSK9 reduces LDL cholesterol in mice
Read More
Preliminary results presented from first-in-human study of ACTR-707 in combination with rituximab
Read More
Vecabrutinib shows preliminary evidence of activity in advanced B-cell malignancies
Read More
Bristol-Myers Squibb presents phase Ib/II data for ulocuplumab in multiple myeloma
Read More
Higher toxicity and lower adherence for alternative palbociclib dosing schedule in breast cancer
Read More
BAT-8003, a novel anti-Trop-2 ADC with promising activity in TNBC mouse models
Read More
OncoSec reports updated tumor response data for KEYNOTE-695 study
Read More
Lilly and AC Immune enter agreement to research and develop tau aggregation inhibitors
Read More
Rodin Therapeutics initiates phase I study of RDN-929
Read More
GARDP to screen libraries from Eisai and Takeda for new antibiotics
Read More
OBI Pharma opens phase III trial of adagloxad simolenin and OBI-821 for high-risk early-stage TNBC
Read More
Virginia Tech collaborates with NIH to study ML-351 for chronic pain
Read More
Mutation in orexin receptor is associated with panic disorder development and response to therapy
Read More
Targeting alpha-synuclein can mitigate stroke damage
Read More
Czech Academy of Sciences institutes patent PGE2 production inhibitors
Read More
Cancer Research Technology discovers BCL-6 inhibitors
Read More
Ono Pharmaceutical identifies new prostanoid EP4 receptor antagonists
Read More
Chinese researchers divulge RORC antagonists
Read More
Protagonist begins phase I study of PN-10943 for inflammatory bowel disease
Read More
Seliforant shown not to affect vigilance, cognitive performance during motion stimulus
Read More
Phase I primary endpoint met in phase I/II study of NC-6300
Read More
Rhythm begins phase III trial of setmelanotide in Bardet-Biedl syndrome and Alstrom syndrome
Read More
Aptevo initiates phase I/Ib study of APVO-436 for AML and MDS
Read More